Browsing: Mortality Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for mortality risk analysis, commentary and insights.
During March, the estimated cost to transfer retiree pension risk to an insurer in a competitive bidding process climbed from 101.7% to 102.5% of a plan’s accounting liabilities.
Gokul Sudarsana, Chief Investment Officer of HSCM’s Life strategy and Co-Chief Investment Officer of the Firm’s Re/Insurance strategy.
Those still trying to understand any potential future impact of Covid-19 on mortality are conducting an exercise in futility.
The International Capital Standard (ICS) introduces a new approach to discounting illiquid liabilities — one that includes an explicit credit risk premium. But how does it compare to Solvency II’s Fundamental Spread? And what might it mean for UK insurers already familiar with the Matching Adjustment?
Potential new entrants seeking to get a piece of the life insurance-based permanent capital action have a few options.
Universal life insurance policy application activity was yet again lower in March when compared to the prior year, seeing an 8.7% reduction compared to 2023.
Recent months have delivered two significant developments that could profoundly impact life expectancy for those with chronic kidney disease.
As our population ages, the significance and frequency of falls increases. This affects life expectancy as well as morbidity and mortality.
Many firms maintain a longevity risk capital model, making sure the methodology remains relevant and proportionate to the risk. We shine a spotlight on these models here, considering how they may evolve with post-pandemic data and Solvency II reforms.
Those advising insurance companies and pension schemes on mortality are paying very close attention to developments with anti-obesity medicines.